CXCR6 and neoplasm: To determine whether skin CXCR6−/−CD8 TRM cells were capable of providing tumor protection independently from the lymphoid memory compartment, MAV was induced as previously described and then mice were treated with FTY720 beginning 1 wk prior to tumor re-challenge (Fig 1A).